Neumora Therapeutics Inc (NMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 70,936 | 62,922 | 76,646 | 63,822 | 60,074 |
| Operating Income | -70,936 | -62,922 | -76,646 | -63,822 | -60,074 |
| Other Income | 3,049 | 4,103 | 4,152 | 5,247 | 6,353 |
| Pre-tax Income | -67,887 | -58,819 | -72,494 | -58,575 | -53,721 |
| Income Tax | 105 | N/A | 53 | 125 | N/A |
| Net Income Continuous | -67,992 | -58,819 | -72,547 | -58,700 | -53,721 |
| Net Income | $-67,992 | $-58,819 | $-72,547 | $-58,700 | $-53,721 |
| EPS Basic Total Ops | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 |
| EPS Basic Continuous Ops | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 |
| EPS Diluted Total Ops | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 |
| EPS Diluted Continuous Ops | -0.42 | -0.37 | -0.45 | -0.37 | -0.34 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -0.37 | -0.45 | N/A | N/A |
| EBITDA(a) | $-72,068 | $-63,846 | $-77,816 | $-65,827 | $-61,063 |